




























Macroautophagy (referred to as autophagy hereafter) is 
a highly conserved lysosome-mediated catabolic 
process, which can deal with the bulk degradation of 
cytoplasmic proteins as well as small organelles. 
Although the activation of autophagy can be acutely 
induced by nutrient deprivation, it is also known that 
cells exhibit a basal level of autophagy activity. Thus, 
autophagy plays important roles in the fine-tuning of 
energy homeostasis and the quality control of proteins 
and small organelles [1,2].  
 
In addition to metabolic stress, it has been shown that 
autophagy can also be induced by various cytotoxic 
stresses. Not surprisingly, increasing evidence has 
shown that autophagy is involved in a number of 
pathophysiologies, including aging and age-related 
diseases (cancer, atherosclerosis, and neuro-
degeneration), and innate and adaptive immunity [3]. It 
is still not entirely clear, however, how such a catabolic 
program contributes to the cytotoxic stress response. 
Since autophagy is thought to be a survival as well as a 
non-apoptotic cell death mechanism, it could be an 
effector for or against stress responsive phenotypes 































Replicative senescence (RS) and oncogene-induced 
senescence (OIS) 
 
Cellular senescence was originally defined as 
‘irreversible’ cell cycle arrest caused by replicative 
exhaustion in cultured human diploid fibroblasts 
(HDFs) [6]. Later, it was shown that this ‘replicative 
exhaustion’ is essentially telomere shortening, which 
activates a persistent DNA damage response [7]. The 
senescence trigger is, however, not restricted to 
telomere dysfunction. In 1997, Serrano et al. showed 
that oncogenic Ras, which can transform immortalized 
cells, induces a senescence-like phenotype in normal 
HDFs [8]. This is rather paradoxical, but it was shown 
that the initial response of cells to oncogenic Ras is 
hyper-proliferation. Thus, it was proposed that cells 
somehow sense this abnormal proliferation, and 
undergo senescence as a delayed response to counter the 
oncogenic signals [9]. It is conceivable that these 
’delayed responses’ would include effector mechanisms 
of senescence, and understanding these mechanisms 
would provide insights into senescence-associated 
pathophysiologies, including aging and cancer. Indeed, 
OIS in culture has been a very useful  system for the  
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effector mechanisms, such as epigenetic gene regulation 
and chromatin modifications, DNA damage response, 
negative feedback in the PI3K pathway, and 
senescence-associated secretory phenotype 
(SASP)/senescence-mess secretome (SMS) [10-14]. 
Our recent study has added autophagy to the list of OIS 
effector mechanisms [15]. 
 
Irrespective of the triggers, senescence shares many, if 
not all, of the effector mechanisms identified in OIS 
systems to some extent. Therefore it is not surprising 
that autophagy is also implicated in RS [16]. However, 
despite the similarity of the endpoint between RS and 
OIS, the modes of senescence establishment are 
distinct: RS involves modest but long-term exposure of 
cells to stress and HDFs reach a senescent state over 
several months, while OIS establishment is a more 
acute and dynamic process. It remains to be addressed 
how these distinct conditions share the regulatory 
mechanisms of autophagy and its downstream effects. 
 
Based on the intensity of the stress and acuteness of the 
process, RS and OIS may reflect natural aging and age-
related disease (e.g. cancer and atherosclerosis), 
respectively. Interestingly, many senescence effector 
mechanisms, including autophagy, have also been 
implicated in both aging and age-related disease [3,17-
20]. Autophagy in lower eukaryotes has been shown to 
be critical for the anti-aging effects of dietary restriction 
and negative modulation of insulin-signalling [21-24]. 
In contrast to its anti-aging effect, as shown in various 
models, autophagy can have either pro- or anti-
tumorigenic activity depending on the context [3,20]. 
Thus it is possible that the same cellular machinery 
plays distinct roles ageing and age-related diseases.  
 
In RS, Gamerdinger et al. (2009) showed that there is a 
gradual shift from the proteasome pathway to 
autophagy within polyubiquitinated protein degradation 
systems. This shift is mediated through at least two 
members of the BAG (Bcl-2-associated athanogene) 
protein family, which can bind to chaperones of the 
Hsc/HSP70 family and thereby modulate protein quality 
control. They showed that BAG1 and BAG3 positively 
regulate the proteasomal and autophagic pathways, 
respectively, and that BAG1 and BAG3 levels are 
reciprocally regulated during RS, in which the 
BAG3/BAG1 ratio is elevated [16].  
 
The increase of BAG3/BAG1 ratio and activation of 
autophagy is also found in tissue aging, thus, it is not 
limited to in vitro ‘cell aging’. Gamerdinger et al. 
(2009) found a similar age-related correlation between 
autophagy and the BAG3/BAG1 ratio in rodent brains. 
Considering the age-dependent accumulation of 
damaged proteins (particularly due to oxidative stress), 
the role of autophagy in this case may be classic 
‘quality control’ of proteins and other macromolecules. 
This is also consistent with the anti-aging role of 
autophagy as described earlier. However, it has also 
been noted that global autophagy capacity declines with 
age in vivo [25,26]. How can one reconcile the apparent 
discrepancy? First, it is possible that the extent to which 
autophagy activity changes is different depending on 
cell type. It has been demonstrated in aged brains that 
neurons, but not astrocytes, show upregulated autophagy 
[16]. Second, it is also possible that it is the basal activity 
and metabolic regulation of autophagy that decline 
during aging, but cytotoxic stress-induced autophagy 
may not be severely affected particularly in long-lived 
cells, which are susceptible to the accumulation of 
oxidative stress. Interestingly, it was recently reported 
that progeroid mouse models exhibit an extensive 
activation of the basal autophagy [27]. It still remains to 
be elucidated, however, whether the chronic activation of 
autophagy in these mice is a protective reaction against 
the causal elements associated with premature aging 
symptoms or that autophagy actively contributes to the 
phenotype. This study, in conjunction with the 
observations by Gamerdinger et al. (2009), suggests that 
alteration of autophagy activity during aging and the 
functional implications of autophagy in age-associated 
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If autophagy is involved in the long-term quality control 
of cytoplasmic macromolecules, as proposed in 
Gamerdinger (2009), what is the acute role of 
autophagy during OIS? To ask this question, we have 
focused on its highly dynamic nature. This is more 
obvious when inducible oncogenes are used, such as 4-
hydroxytamoxifen (4-OHT)-inducible ER:Ras fusion 
protein, which is comprised of a mutant form of the 
estrogen receptor ligand-binding domain and 
constitutively active H-RasV12 [15]. This inducible 
system allows us to focus on the transition phase, which 
lies between the initial mitotic burst after Ras-induction, 
and the static senescence phase. It is possible that the 
most dramatic phenotypic remodelling and cellular 
adjustments to the new environment occur during this 
transition phase.  
 
One obvious mechanism that is responsible for this 
transition is a global transcription change. We and 
others previously described a unique chromatin 
structure – senescence associated heterochromatic foci 
(SAHFs) – which seem to play a role in transcriptional 
regulation during senescence [10,28,29]. Indeed, many 
senescence-associated genes are upregulated during the 
transition phase, including a large number of secretory 
proteins. Among these, IL6 and IL8, an inflammatory 
cytokine and chemokine respectively, have recently 
been shown to reinforce the senescence phenotype, thus 
representing another senescence effector mechanism – 
SASP/SMS [30-32]. The timing of IL6/8 induction has 
been correlated with autophagy activation during the 
transition phase. Strikingly, RNAi-mediated repression 
of  Atg5 or Atg7 (essential genes for autophagy) 
suppresses IL6/8 production, indicating a functional 
relevance of autophagy in senescence. Although it is 
still unclear exactly how autophagy facilitates IL6/8 
production, we have shown that the transcription levels 
of these genes are often even higher when Atg5 or Atg7 
are knocked-down, indicating that the positive 
regulation of these genes by autophagy occurs at the 
post-transcriptional level. Thus IL6/8, which are acutely 
produced  en masse, seem to be regulated in a 
cooperative manner by mRNA and protein synthesis 
(Figure 1). Massive induction of autophagy and the 
resultant efficient protein turnover might provide 
another layer of gene expression control – at least for 





Metabolism is a very dynamic and robust process, thus 
interpreting 'snapshots' of metabolic processes can be 
difficult. Our recent study focusing on the dynamic 
phase of OIS highlighted the distinct role of autophagy 
in controlling protein quantity in OIS. Extensive 
characterization of autophagy's distinct and shared roles 
in RS and OIS would be beneficial to further understand 
the mechanisms by which autophagy has diverse effects 
in different contexts. In addition to its downstream 
effects, it is also important to understand how 
autophagy is regulated during senescence. Consistent 
with a previous report [12], we have shown that 
components of the PI3K pathway – including mTOR, a 
negative regulator of autophagy – are attenuated after 
their acute activation following Ras expression during 
the transition phase of OIS [15,33]. Although the long-
term fluctuation of mTOR activity during the 
senescence phase remains to be fully characterized, our 
study raises an interesting question: how protein 
synthesis (positively regulated by mTOR) and 
autophagy (negatively regulated by mTOR) are 
activated during the senescence transition. Interestingly, 
recent reports show that mTOR inhibition by rapamycin 
decelerates senescence [34,35]. mTOR-regulated 
catabolic and anabolic processes seems to be somehow 
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